Assignee
SIRONAX LTD
KY·2 granted patents·13 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
15 records- 0154US12129221B2Difluoro phenyl amide RIP1 inhibitorSIRONAX LTD·Filed 2021·Granted Oct 29, 2024·0 cites·4 claims
- 0254US2024409501A1Cyrstalline forms of rip1 inhibitorSIRONAX LTD·Filed 2022·Application pending·0 cites
- 0354US2026078130A1Nampt modulators, preparations, and uses thereofSIRONAX LTD·Filed 2023·Application pending·0 cites
- 0454US2025179061A1Rip1 modulators, preparations, and uses thereofSIRONAX LTD·Filed 2023·Application pending·0 cites
- 0550US12454529B2Piperazine cyclic ureasSIRONAX LTD·Filed 2021·Granted Oct 28, 2025·0 cites·28 claims
- 0650US2024217963A1Receptor-interacting protein 1 inhibitors, preparations, and uses thereofSIRONAX LTD·Filed 2022·Application pending·0 cites
- 0750US2024294508A1Rip1 modulators including azetidine cyclic ureas, preparations, and uses thereofSIRONAX LTD·Filed 2022·Application pending·0 cites
- 0849US2024327393A1Ferroptosis modulators, preparations, and uses thereofSIRONAX LTD·Filed 2022·Application pending·0 cites
- 0949US2025236613A1Sarm1 modulators, preparations, and uses thereofSIRONAX LTD·Filed 2022·Application pending·0 cites
- 1049US2025320184A1Sarm1 modulators, preparations, and uses thereofSIRONAX LTD·Filed 2023·Application pending·0 cites
- 1147US2024360114A1Ferroptosis modulators, preparations, and uses thereofSIRONAX LTD·Filed 2022·Application pending·0 cites
- 1247US2021292305A1Cyclic UreasSIRONAX LTD·Filed 2021·Application pending·0 cites
- 1346US2023416226A1Azetidine Cyclic UreasSIRONAX LTD·Filed 2021·Application pending·0 cites
- 1446US2023192662A1Receptor-Interacting Protein 1 Inhibitors Including Piperazine Heterocyclic Amide UreasSIRONAX LTD·Filed 2021·Application pending·0 cites
- 1544US2023159492A1Ferroptosis inhibitors - diarylamine para-acetamidesSIRONAX LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SIRONAX LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →